Monia Brett P's Form 4 filing
Ionis Pharmaceuticals Inc (IONS) · filed Jun 26, 2026
- Accession no.
- 0000874015-26-000212
- Filed
- Jun 26, 2026
- Trade date
- Jun 24-26, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $6.83M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Monia Brett PCIK 0001537529 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Common Stock | MOption exerciseAcquired | +14,565 | $32.60 | +$474,819 | 260,136 | Direct | |
| Jun 24, 2026 | Common Stock | SSaleDisposed | −14,565 | $78.41 | −$1,142,041.65 | 245,571 | Direct | |
| Jun 25, 2026 | Common Stock | MOption exerciseAcquired | +21,072 | $32.60 | +$686,947.2 | 266,643 | Direct | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −21,072 | $78.49 | −$1,653,941.28 | 245,571 | Direct | |
| Jun 26, 2026 | Common Stock | MOption exerciseAcquired | +50,000 | $56.78 | +$2,839,000 | 295,571 | Direct | |
| Jun 26, 2026 | Common Stock | SSaleDisposed | −50,000 | $80.59 | −$4,029,500 | 245,571 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Common Stock | MOption exerciseDisposed | −14,565 | $0.00 | $0 | 21,072 | Direct | |
| Jun 25, 2026 | Common Stock | MOption exerciseDisposed | −21,072 | $0.00 | $0 | 0 | Direct | |
| Jun 26, 2026 | Common Stock | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 99,872 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.